skip to main | skip to sidebar

THE AMPYRA CHANNEL

NEWS & TIPS!

Saturday

VIDEO: Acorda Therapeutics (AMPYRA) CEO Ron Cohen on how the partial government shutdown affects the pharmaceutical industry



CLICK TO WATCH THIS 3 MINUTE VIDEO WITH THE CEO OF THE COMPANY THAT MAKES AMPYRA TALK ABOUT "NO NEW DRUGS"


Posted by Josi Creek Unknown at 1:20 PM
Labels: Ampyra (Dalfampridine)
Newer Post Older Post Home

Blog Archive

  • ►  2016 (8)
    • ►  May (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2015 (16)
    • ►  July (1)
    • ►  June (3)
    • ►  March (1)
    • ►  February (1)
    • ►  January (10)
  • ►  2014 (42)
    • ►  April (41)
    • ►  February (1)
  • ▼  2013 (12)
    • ▼  October (7)
      • AMPYRA IMPROVES WALKING SPEED, WALKING ENDURANCE ...
      • Treatment with dalfampridine (AMPYRA) resulted in ...
      • ECTRIMS UPDATE #2: BIOGEN HAS 3 NEW MS TREATMENTS ...
      • VIDEO: Acorda Therapeutics (AMPYRA) CEO Ron Cohen ...
      • STUDY: AMPYRA (Dalfampridine) improves walking spe...
      • Tecfidera & Ampyra Show Potential for Quality of L...
      • A SERVICE DEVELOPMENT AUDIT OF FAMPRIDINE (AMPYRA...
    • ►  September (2)
    • ►  July (2)
    • ►  May (1)
  • ►  2010 (26)
    • ►  May (1)
    • ►  April (13)
    • ►  March (12)